Neomed Labs Pacific Biomarkers PAIRimmune are now Nexelis
News, Events & Publications × clear filter

or filter by:

subscribe now

Press Release

Timothy McGrath Appointed Chief Operating Officer of Newly Merged NEOMED-LABS / Pacific Biomarkers

March 28, 2019 | Press Release

LAVAL, QC, and SEATTLE, WA, March 28, 2019 – The newly merged NEOMED-LABS / Pacific Biomarkers, an immunology centric service […]

read more

Ampersand Capital Partners Acquires Pacific Biomarkers and Merges Company with NEOMED-LABS

November 19, 2018 | Press Release

WELLESLEY, MA, LAVAL, QC, and SEATTLE, WA, November 19, 2018 - Ampersand Capital Partners announced today that it has completed […]

read more

FDA Qualifies Safety Biomarker Panel Developed and Validated by Pacific Biomarkers for Kidney Injury

September 24, 2018 | Press Release

SEATTLE, WASHINGTON, November 5, 2018 – The U.S. Food and Drug Administration (FDA), announced that the qualification of the Predictive […]

read more

Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute

September 4, 2018 | Press Release

LAVAL, QC. and WELLESLEY, MA., September 4, 2018 – Ampersand Capital Partners, together with the management team of NEOMED-LABS and […]

read more

NEOMED-LABS Renews Strategic Agreement with GSK

May 31, 2018 | Press Release

Laval, May 31, 2018 – Laval headquartered NEOMED-LABS, a global leader in the clinical immunology field, announces today a 3-year […]

read more

1 2

back to top
contact us now

contact us

  • This field is for validation purposes and should be left unchanged.